Analysis of anandamide- and lysophosphatidylinositol-induced inhibition of the vasopressor responses produced by sympathetic stimulation or noradrenaline in pithed rats
2013
Marichal-Cancino, Bruno A. | Manrique-Maldonado, Guadalupe | Altamirano-Espinoza, Alain H. | Ruiz-Salinas, Inna | González-Hernández, Abimael | MaassenVanDenBrink, Antoinette | Villalón, Carlos M.
The endocannabinoid system exhibits multiple functions in cardiovascular regulation mainly by cannabinoid (CB₁ and CB₂) receptors, vanilloid TRPV1 receptors and, probably, by the orphan G protein-coupled receptor 55 (GPR55). Hence, the role of these receptors was investigated in Wistar pithed rats on anandamide- and lysophosphatidylinositol (LPI)-induced inhibition of the vasopressor responses induced by preganglionic (T₇-T₉) stimulation of the vasopressor sympathetic outflow or i.v. bolus injections of noradrenaline. The corresponding frequency- and dose-dependent vasopressor responses were analyzed before and during i.v. continuous infusions of anandamide (CB₁, CB₂, TRPV1 and GPR55), JWH-015 (CB₂) and LPI (GPR55) in animals receiving (i.v.) the antagonists NIDA41020 (CB₁), AM630 (CB₂), capsazepine (TRPV1) and/or cannabidiol (GPR55). Anandamide (0.1-3.1μg/kgmin) inhibited the vasopressor responses by electrical stimulation, but not those by noradrenaline; while LPI (5.6–10μg/kgmin) inhibited both responses. In contrast, JWH-015 (5.6–10μg/kgmin) failed to induce sympatho-inhibition. Anandamide-induced sympatho-inhibition was: (i) dose-dependently blocked by 31 and 100μg/kg NIDA41020; (ii) slightly blocked by 310μg/kg AM630 or 31μg/kg cannabidiol; and (iii) unaffected by 310μg/kg capsazepine. Moreover, LPI-induced inhibition of both vasopressor responses was blocked and abolished by 10 and 31μg/kg cannabidiol, respectively, and weakly blocked by 100μg/kg NIDA41020. Thus, the sympatho-inhibition by anandamide is primarily mediated by cannabinoid CB₁ and, minimally, by cannabidiol-sensitive receptors. In contrast, LPI-induced inhibition of both responses seems to be mainly mediated by postjunctional cannabidiol-sensitive (presumably endothelial GPR55) receptors.
显示更多 [+] 显示较少 [-]